サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1387329

慢性腎臓病（CKD）市場レポート：2030年までの動向、予測、競合分析

Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

慢性腎臓病（CKD）市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月31日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

慢性腎臓病（CKD）の動向と予測

世界の慢性腎臓病（CKD）市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定836億米ドルに達すると予想されます。この市場の主な促進要因は、慢性腎臓病（CKD）患者の増加、技術的に進歩した製品や診断検査の利用です。世界の慢性腎臓病（CKD）市場は、病院と透析センター市場にビジネスチャンスがあり、将来性が期待されます。

慢性腎臓病（CKD）市場の洞察

Lucintelの予測では、ヘルスケア専門家が患者を効果的に治療するための新薬や治療の導入より、医薬品が予測期間中に高い成長を遂げる見込みです。

この市場の中で、病院はCKDの治療と管理に必要な高度な設備を備えているため、高い成長が見込まれます。

アジア太平洋地域は、多くの患者が存在し、質の高いヘルスケアに対する需要が高まっていることから、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の慢性腎臓病（CKD）市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の慢性腎臓病（CKD）市場動向（2018～2023年）と予測（2024～2030年）
  • 治療別の世界の慢性腎臓病（CKD）市場
    • 医薬品
    • 透析
  • 最終用途別の世界の慢性腎臓病（CKD）市場
    • 病院
    • 透析センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の慢性腎臓病（CKD）市場
  • 北米の慢性腎臓病（CKD）市場
  • 欧州の慢性腎臓病（CKD）市場
  • アジア太平洋の慢性腎臓病（CKD）市場
  • その他地域の慢性腎臓病（CKD）市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 治療別の世界の慢性腎臓病（CKD）市場の成長機会
    • 最終用途別の世界の慢性腎臓病（CKD）市場の成長機会
    • 地域別の世界の慢性腎臓病（CKD）市場の成長機会
  • 世界の慢性腎臓病（CKD）市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の慢性腎臓病（CKD）市場の能力拡大
    • 世界の慢性腎臓病（CKD）市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer
目次

Chronic Kidney Disease Trends and Forecast

The future of the global chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets. The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.

A more than 150-page report is developed to help in your business decisions.

Chronic Kidney Disease by Segment

The study includes a forecast for the global chronic kidney disease by treatment, end use, and region.

Chronic Kidney Disease Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Drugs
  • Dialysis

Chronic Kidney Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Dialysis Center
  • Others

Chronic Kidney Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Chronic Kidney Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic kidney disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic kidney disease companies profiled in this report include-

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer

Chronic Kidney Disease Market Insights

Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.

Within this market, hospitals is expected to witness the higher growth as it is equipped with advanced facilities, which are required to treat and manage CKD

APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.

Features of the Global Chronic Kidney Disease Market

Market Size Estimates: Chronic kidney disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chronic kidney disease market size by treatment, end use, and region in terms of value ($B).

Regional Analysis: Chronic kidney disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatments, end uses, and regions for the chronic kidney disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic kidney disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the chronic kidney disease market size?

Answer: The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030.

Q2. What is the growth forecast for chronic kidney disease market?

Answer: The global chronic kidney disease market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the chronic kidney disease market?

Answer: The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.

Q4. What are the major segments for chronic kidney disease market?

Answer: The future of the chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets.

Q5. Who are the key chronic kidney disease market companies?

Answer: Some of the key chronic kidney disease companies are as follows:

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer

Q6. Which chronic kidney disease market segment will be the largest in future?

Answer: Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.

Q7. In chronic kidney disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the chronic kidney disease market by treatment (drugs and dialysis), end use (hospital, dialysis center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chronic Kidney Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Chronic Kidney Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Chronic Kidney Disease Market by Treatment
    • 3.3.1: Drugs
    • 3.3.2: Dialysis
  • 3.4: Global Chronic Kidney Disease Market by End Use
    • 3.4.1: Hospital
    • 3.4.2: Dialysis Center
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Chronic Kidney Disease Market by Region
  • 4.2: North American Chronic Kidney Disease Market
    • 4.2.2: North American Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.3: European Chronic Kidney Disease Market
    • 4.3.1: European Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.3.2: European Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.4: APAC Chronic Kidney Disease Market
    • 4.4.1: APAC Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.4.2: APAC Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.5: ROW Chronic Kidney Disease Market
    • 4.5.1: ROW Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.5.2: ROW Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Chronic Kidney Disease Market by Treatment
    • 6.1.2: Growth Opportunities for the Global Chronic Kidney Disease Market by End Use
    • 6.1.3: Growth Opportunities for the Global Chronic Kidney Disease Market by Region
  • 6.2: Emerging Trends in the Global Chronic Kidney Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Chronic Kidney Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Kidney Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Baxter International
  • 7.2: Teva Pharmaceutical Industries
  • 7.3: AstraZeneca
  • 7.4: Johnson & Johnson
  • 7.5: AbbVie
  • 7.6: Becton
  • 7.7: Dickinson and Company
  • 7.8: B. Braun
  • 7.9: F. Hoffmann-La Roche
  • 7.10: Pfizer